SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-005792
Filing Date
2018-08-07
Accepted
2018-08-07 08:02:08
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080718p.htm 10-Q 767882
2 EXHIBIT 10.1 exh_101.htm EX-10.1 36018
3 EXHIBIT 31.1 exh_311.htm EX-31.1 9141
4 EXHIBIT 31.2 exh_312.htm EX-31.2 9069
5 EXHIBIT 32.1 exh_321.htm EX-32.1 6165
  Complete submission text file 0001171843-18-005792.txt   2713301

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prto-20180630.xml EX-101.INS 366341
7 XBRL SCHEMA FILE prto-20180630.xsd EX-101.SCH 30746
8 XBRL CALCULATION FILE prto-20180630_cal.xml EX-101.CAL 23974
9 XBRL DEFINITION FILE prto-20180630_def.xml EX-101.DEF 197915
10 XBRL LABEL FILE prto-20180630_lab.xml EX-101.LAB 183641
11 XBRL PRESENTATION FILE prto-20180630_pre.xml EX-101.PRE 214158
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 18996348
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences